Roy Maute, PhD
Co-Founder
Head of Biology

Dr. Maute has broad experience in the field of immunology, and in particular cancer immunology, through his training in the labs of Riccardo Dalla-Favera at Columbia University and Irving Weissman at Stanford University. During his post-doctoral work, Dr. Maute worked to develop engineered protein drugs to modulate the immune system, and identified pathways that present novel avenues for cancer immunotherapy. Prior to his postdoctoral training at Stanford, Dr. Maute received a B.A. in Molecular and Cell Biology at the University of California, Berkeley, and a Ph.D. in Genetics from Columbia University. Dr. Maute received the 2013 Richard C. Parker Memorial award from Columbia University for his innovative work in the field of immunology, and was supported as an Irvington Postdoctoral Fellow by the Cancer Research Institute, an organization with a long-standing commitment to cancer immunotherapy. He now leads Ab Initio's research efforts as Head of Biology.